Home - Products - Others - Other Targets - 1-Aminohydantoin hydrochloride

1-Aminohydantoin hydrochloride

CAS No. 2827-56-7

1-Aminohydantoin hydrochloride( —— )

Catalog No. M13859 CAS No. 2827-56-7

1-Amino Hydantoin Hydrochloride is an organic compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Aminohydantoin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Amino Hydantoin Hydrochloride is an organic compound.
  • Description
    1-Amino Hydantoin Hydrochloride is an organic compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2827-56-7
  • Formula Weight
    151.55
  • Molecular Formula
    C3H6ClN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    Cl.NN1CC(=O)NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liu W, et al. J Agric Food Chem. 2007 Aug 22;55(17):6829-34.
molnova catalog
related products
  • Cannabidivarin

    Cannabidivarin is a potent inhibitor against gamma 2 subunit of GABAA receptors. it may serve as a novel drug with definite control over childhood absence epilepsy.

  • Lobaplatin (D-19466)

    Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexes. Lobaplatin (D-19466) shows activity for a variety of tumour types and is a promising antitumour chemotherapeutic agent.

  • Zilovertamab

    Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer.